Press releases

Investigational New Drug (IND)-enabling Studies for Sachi Bio's lead molecule

Sachi Bio's lead program NI112 shows excellent Safety-Toxicity, brain-delivery, and biodistribution profile in Investigational New Drug...

Sachi Bio lead programs to support NASA Missions & counter debilitating diseases on Earth

"Sachi Bio has successfully advanced it's lead program towards translation for a range of neurodegenerative diseases, as well as a...

Sachi Bio wins US National Academy of Medicine Sponsored "Healthy Longevity Global Challenge" for Healthy Aging

Starting in 2030, we will witness a historic milestone as the elderly population surpasses the youth for the first time ever. This...

Ph: 720-361-2159

3000 Airport Drive, Unit 201,

Erie, CO 80516

Subscribe to Our Newsletter